Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
Shehab Mohamed, Hematologist at Hamad Medical Corporation, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in eJHaem, adding:
“Here we go!
We share our newly published systematic review in eJHaem!
Our study, ‘Clinicopathologic Characteristics of Somatic TP53 Mutations in Philadelphia Chromosome–Negative Myeloproliferative Neoplasms: A Systematic Review,’ synthesizes the available evidence on the prevalence, allelic characteristics, and clinical outcomes of TP53-mutated MPNs.
Across 11 retrospective cohorts comprising 603 patients, TP53 mutations were enriched in advanced disease, with particularly poor outcomes in myelofibrosis and accelerated/blast-phase MPN.
Importantly, the prognostic impact of single-hit versus multi-hit TP53 appeared strongly dependent on disease phase.
Key findings included a pooled TP53 mutation prevalence of 3% overall, rising to 10% in MF or AP/BP-MPN cohorts, a mean VAF of 37.5%, and only 16% allo-HCT utilization.
Median overall survival in AP/BP-MPN was approximately 4.5–6 months.
A sincere thank you to the entire team and all our collaborators for their valuable contributions, dedication, and teamwork that made this study possible.”
Title: Clinicopathologic Characteristics of Somatic TP53 Mutations in Philadelphia Chromosome–Negative Myeloproliferative Neoplasms: A Systematic Review
Authors: Mahmood Aldapt, Rasha Kaddoura, Ahmed O. Saleh, Mostafa Najim, Ahmad Salem, Abdulrahman F. Al-Mashdali, Bassam Muthanna, Ruba Adel Aweer, Marrita Rabadi, Shehab F. Mohamed
Other posts featuring Shehab Mohamed on Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience